Wuestec restructures Samsung relationshipAs Wuestec Medical gears up for commercialization of its new low-cost digital x-ray system, the U.S. x-ray company has restructured its relationship with Korean partner Samsung. Wuestec has taken over
As Wuestec Medical gears up for commercialization of its new low-cost digital x-ray system, the U.S. x-ray company has restructured its relationship with Korean partner Samsung. Wuestec has taken over full control of Samsungs interest in DigiX, a Canadian digital development joint venture formed to develop a CCD-based digital x-ray system. Wuestec will operate the venture as an internal R&D arm.
The joint ventures work had paired Samsungs expertise in CCD technology with Wuestecs capabilities in developing conventional x-ray units. Wuestec had displayed the product of DigiXs work, DX-1480, at the 1998 RSNA meeting.
Wuestec made the decision to buy out Samsung to assume more control over its supply of digital x-ray components, according to COO Martin Porter. The company purchased Samsungs interest in DigiX using cash, notes payable, and an equity stake in privately held Wuestec. Wuestec declined to comment on the price or what percentage of the Mobile, AL-based firm Samsung now owns.
DX-1480 is priced at $197,500, a level significantly below the $350,000 to $400,000 price range cited for other digital radiography (DR) systems. Wuestec officials have positioned DX-1480 to compete head-on with standard analog x-ray systems.
The company has lined up 70 x-ray dealerships in the U.S. to handle DX-1480 and hopes to begin installations of the new system this month. The firms own sales staff will handle national accounts. Internationally, Wuestec has formed distributor relationships in Europe, Asia/Pacific, and the Middle East. The company has begun installing the first production unit of DX-1480 at its clinical site at the University of South Alabama, also in Mobile, AL.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Strategies to Reduce Disparities in Interventional Radiology Care
March 19th 2025In order to help address the geographic, racial, and socioeconomic barriers that limit patient access to interventional radiology (IR) care, these authors recommend a variety of measures ranging from increased patient and physician awareness of IR to mobile IR clinics and improved understanding of social determinants of health.
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.